Metastatic Hormone Refractory Prostate Cancer Recruiting Phase 4 Trials for Prednisone (DB00635)

Also known as: Metastatic hormone refractory Prostate cancer / Metastatic Prostate cancer / Prostate cancer metastatic / Metastatic Prostate Carcinoma / Carcinoma of the prostate metastatic / Prostatic cancer metastatic

DBCOND0036371 (Metastatic Hormone Refractory Prostate Cancer)Recruiting4 IdentifierTitlePurposeDrugs
NCT03016741Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate CancerSupportive Care